1887

Chapter 21 : Lipids

Authors: K. Frank Austen1, Yoshihide Kanaoka1
VIEW AFFILIATIONS HIDE AFFILIATIONS
Affiliations: 1: Department of Medicine, Harvard Medical School, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA 02115
Content Type: Monograph
Publication Year: 2004

Category: Immunology; Clinical Microbiology

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Preview Magnify
Zoom in
Zoomout

Lipids, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817671/9781555812911_Chap21-1.gif /docserver/preview/fulltext/10.1128/9781555817671/9781555812911_Chap21-2.gif

Abstract:

Lipids are an essential constituent of cell membranes and are sources of energy. Lipid mediator generation can be entirely innate or composite via an adaptive immune step. This chapter addresses only primary innate or exogenous signals assessed in vitro and in vivo. In vivo discussion is limited to studies in null mouse strains for clarity. The activation of phospholipase A (PLA) with release of arachidonic acid provides the substrate for all eicosanoids, namely, prostanoids and leukotrienes (LTs). Although certain residual lysophospholipids by acetylation become platelet-activating factor (PAF), other lysophospholipids are generated by more complex pathways. PLA comprises a diverse family of enzymes that cleave the -2 position of glycerophospholipids to form a fatty acid and a lysophospolipid. PLA is involved in the digestion of phospholipids in the diet and in the metabolism and turnover of phospholipids in cell membranes. Lysophosphatidic acid (LPA) and S1P are bioactive lysophospholipids with cell functions that include growth, inhibition of apoptosis, differentiation, migration, and cytoskeletal rearrangement. The major biosynthetic pathway of LPA is initiated by the action of phospholipase D on phospholipids to form phosphatidic acid and then the cleavage of the -2 position of the fatty acid by phosphatidic acid-specific PLA to form LPA. Two lysophospholipds containing lysophosphorylcholine, namely, sphingosylphosphorylcholine (SPC) and lysophosphatidylcholine (LPC), are involved in many biological processes including cell proliferation and growth inhibition.

Citation: Austen K, Kanaoka Y. 2004. Lipids, p 417-432. In Kaufmann S, Medzhitov R, Gordon S (ed), The Innate Immune Response to Infection. ASM Press, Washington, DC. doi: 10.1128/9781555817671.ch21

Key Concept Ranking

Mitogen-Activated Protein Kinase Pathway
0.47812906
Tumor Necrosis Factor alpha
0.44693983
0.47812906
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Lipids
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817671.chap21-1,webId=/content/author/10.1128/9781555817671.chap21-1,properties={foaf_givenname=K. Frank, foaf_name=K. Frank Austen, foaf_surname=Austen, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555817671.chap21-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817671.chap21-2,webId=/content/author/10.1128/9781555817671.chap21-2,properties={foaf_givenname=Yoshihide, foaf_name=Yoshihide Kanaoka, foaf_surname=Kanaoka, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555817671.chap21-aff1]]}]]
Citation: Austen K, Kanaoka Y. 2004. Lipids, p 417-432. In Kaufmann S, Medzhitov R, Gordon S (ed), The Innate Immune Response to Infection. ASM Press, Washington, DC. doi: 10.1128/9781555817671.ch21
/content/10.1128/9781555817671.chap21.fig21-1
FIGURE 1

Biosynthetic pathway of prostanoids and thromboxanes. cPLA, cytosolic phospholipase A; PGHS, prostaglandin endoperoxide synthase; PGDS, prostaglandin D synthase; PGES, prostaglandin E synthase; PGFS, prostaglandin F synthase; PGIS, prostacyclin synthase; TXS, thromboxane synthase.

10.1128/9781555817671/fig21-1_thmb.gif
10.1128/9781555817671/fig21-1.gif
Image of FIGURE 1
FIGURE 1

Biosynthetic pathway of prostanoids and thromboxanes. cPLA, cytosolic phospholipase A; PGHS, prostaglandin endoperoxide synthase; PGDS, prostaglandin D synthase; PGES, prostaglandin E synthase; PGFS, prostaglandin F synthase; PGIS, prostacyclin synthase; TXS, thromboxane synthase.

Citation: Austen K, Kanaoka Y. 2004. Lipids, p 417-432. In Kaufmann S, Medzhitov R, Gordon S (ed), The Innate Immune Response to Infection. ASM Press, Washington, DC. doi: 10.1128/9781555817671.ch21
Permissions and Reprints Request Permissions
Download as Powerpoint
/content/10.1128/9781555817671.chap21.fig21-2
FIGURE 2

Biosynthetic pathway of leukotrienes. 5-LO, 5-lipoxygenase; FLAP, 5-LO activating protein; 5-HPETE, 5-hydroperoxyeicosatetraenoic acid; LT, leukotriene; LTAH, LTA hydrolase; LTCS, LTC synthase; γ-GT, γ-glutamyl transpeptidase; γ-GL, γ-glutamyl leukotrienase; DiP, dipeptidase.

10.1128/9781555817671/fig21-2_thmb.gif
10.1128/9781555817671/fig21-2.gif
Image of FIGURE 2
FIGURE 2

Biosynthetic pathway of leukotrienes. 5-LO, 5-lipoxygenase; FLAP, 5-LO activating protein; 5-HPETE, 5-hydroperoxyeicosatetraenoic acid; LT, leukotriene; LTAH, LTA hydrolase; LTCS, LTC synthase; γ-GT, γ-glutamyl transpeptidase; γ-GL, γ-glutamyl leukotrienase; DiP, dipeptidase.

Citation: Austen K, Kanaoka Y. 2004. Lipids, p 417-432. In Kaufmann S, Medzhitov R, Gordon S (ed), The Innate Immune Response to Infection. ASM Press, Washington, DC. doi: 10.1128/9781555817671.ch21
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555817671.chap21
1. Angeli, V.,, C. Faveeuw,, O. Roye,, J. Fontaine,, E. Teissier,, A. Capron,, I. Wolowczuk,, M. Capron,, and F. Trottein. 2001. Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J. Exp. Med. 193: 1135– 1147.
2. Beuckmann, C.T.,, K. Fujimori,, Y. Urade,, and O. Hayaishi. 2000. Identification of mu-class glutathione transferases M2-2 and M3-3 as cytosolic prostaglandin E synthases in the human brain. Neurochem. Res. 25: 733– 738.
3. Bonventre, J. V.,, Z. Huang,, M. R. Taheri,, E. O'Leary,, E. Li,, M. A. Moskowitz,, and A. Sapirstein. 1997. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A 2. Nature 390: 622– 625.
4. Byrum, R. S.,, J. L. Goulet,, R. J. Griffiths,, and B. H. Koller. 1997. Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses. J. Exp. Med. 185: 1065– 1075.
5. Byrum, R. S.,, J. L. Goulet,, J. N. Snouwaert,, R. J. Griffiths,, and B. H. Koller. 1999. Determination of the contribution of cysteinyl leukotrienes and leukotriene B 4 in acute inflammatory responses using 5- lipoxygenase- and leukotriene A 4 hydrolase-deficient mice. J. Immunol. 163: 6810– 6819.
6. Carter, B. Z.,, Z. Z. Shi,, R. Barrios,, and M.W. Lieberman. 1998. Gamma-glutamyl leukotrienase, a gamma-glutamyl transpeptidase gene family member, is expressed primarily in spleen. J. Biol. Chem. 273: 28277– 28285.
7. Chen, X. S.,, J. R. Sheller,, E. N. Johnson,, and C. D. Funk. 1994. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 372: 179– 182.
8. Clark, J. D.,, N. Milona,, and J. L. Knopf. 1990. Purification of a 110-kilodalton cytosolic phospholipase A 2 from the human monocytic cell line U937. Proc. Natl. Acad. Sci. USA 87: 7708– 7712.
9. Clark, J. D.,, L. L. Lin,, R.W. Kriz,, C. S. Ramesha,, L. A. Sultzman,, A.Y. Lin,, N. Milona,, and J. L. Knopf. 1991. A novel arachidonic acid-selective cytosolic PLA 2 contains a Ca 2+-dependent translocation domain with homology to PKC and GAP. Cell 65: 1043– 1051.
10. Contos, J. J.,, N. Fukushima,, J. A. Weiner,, D. Kaushal,, and J. Chun. 2000. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc. Natl.Acad. Sci.USA 97: 13384– 13389.
11. Contos, J. J.,, I. Ishii,, N. Fukushima,, M. A. Kingsbury,, X. Ye,, S. Kawamura,, J. H. Brown,, and J. Chun. 2002. Characterization of lpa 2 (Edg4) and lpa 1/lpa 2 (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa2. Mol. Cell. Biol. 22: 6921– 6929.
12. Cormier, R.T.,, K. H. Hong,, R. B. Halberg,, T. L. Hawkins,, P. Richardson,, R. Mulherkar,, W. F. Dove,, and E. S. Lander. 1997. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat. Genet. 17: 88– 91.
13. Dahlen, S. E.,, J. Bjork,, P. Hedqvist,, K. E. Arfors,, S. Hammarstrom,, J. A. Lindgren,, and B. Samuelsson. 1981. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. USA 78: 3887– 3891.
14. Davies, P.,, P. J. Bailey,, M. M. Goldenberg,, and A. W. Ford-Hutchinson. 1984. The role of arachidonic acid oxygenation products in pain and inflammation. Annu. Rev. Immunol. 2: 335– 357.
15. Devchand, P. R.,, H. Keller,, J. M. Peters,, M. Vazquez,, F. J. Gonzalez,, and W. Wahli. 1996. The PPARalpha-leukotriene B 4 pathway to inflammation control. Nature 384: 39– 43.
16. Dinchuk, J. E.,, B. D. Car,, R. J. Focht,, J. J. Johnston,, B. D. Jaffee,, M. B. Covington,, N. R. Contel,, V. M. Eng,, R. J. Collins,, P. M. Czerniak,, S. A. Gorry,, and J. M. Trzaskos. 1995. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378: 406– 409.
17. Dixon, R. A.,, R. E. Jones,, R. E. Diehl,, C. D. Bennett,, S. Kargman,, and C. A. Rouzer. 1988. Cloning of the cDNA for human 5-lipoxygenase. Proc. Natl. Acad. Sci. USA 85: 416– 420.
18. Dixon, R. A.,, R. E. Diehl,, E. Opas,, E. Rands,, P. J. Vickers,, J. F. Evans,, J.W. Gillard,, and D. K. Miller. 1990. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343: 282– 284.
19. Fourcade, O.,, M. F. Simon,, C. Viode,, N. Rugani,, F. Leballe,, A. Ragab,, B. Fournie,, L. Sarda,, and H. Chap. 1995. Secretory phospholipase A 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80: 919– 927.
20. Funk, C.D.,, O. Radmark,, J.Y. Fu,, T. Matsumoto,, H. Jornvall,, T. Shimizu,, and B. Samuelsson. 1987. Molecular cloning and amino acid sequence of leukotriene A 4 hydrolase. Proc. Natl. Acad. Sci. USA 84: 6677– 6681.
21. Gijon, M. A.,, D. M. Spencer,, A. R. Siddiqi,, J.V. Bonventre,, and C. C. Leslie. 2000. Cytosolic phospholipase A 2 is required for macrophage arachidonic acid release by agonists that do and do not mobilize calcium. Novel role of mitogen-activated protein kinase pathways in cytosolic phospholipase A 2 regulation. J. Biol. Chem. 275: 20146– 20156.
22. Goulet, J. L.,, J.N. Snouwaert,, A. M. Latour,, T.M. Coffman,, and B. H. Koller. 1994. Altered inflammatory responses in leukotriene-deficient mice. Proc. Natl. Acad. Sci. USA 91: 12852– 12856.
23. Graler, M. H.,, and E. J. Goetzl. 2002. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim. Biophys. Acta 1582: 168– 174.
24. Hammarstrom, S. 1981. Metabolism of leukotriene C 3 in the guinea pig. Identification of metabolites formed by lung, liver, and kidney. J. Biol. Chem. 256: 9573– 9578.
25. Hanasaki, K.,, Y. Yokota,, J. Ishizaki,, T. Itoh,, and H. Arita. 1997. Resistance to endotoxic shock in phospholipase A 2 receptor-deficient mice. J. Biol. Chem. 272: 32792– 32797.
26. Haribabu, B.,, M. W. Verghese,, D. A. Steeber,, D. D. Sellars,, C. B. Bock,, and R. Snyderman. 2000. Targeted disruption of the leukotriene B 4 receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. J. Exp. Med. 192: 433– 438.
27. Heise, C. E.,, B. F. O'Dowd,, D. J. Figueroa,, N. Sawyer,, T. Nguyen,, D. S. Im,, R. Stocco,, J. N. Bellefeuille,, M. Abramovitz,, R. Cheng,, D. L. Williams, Jr.,, Z. Zeng,, Q. Liu,, L. Ma,, M. K. Clements,, N. Coulombe,, Y. Liu,, C. P. Austin,, S. R. George,, G. P. O'Neill,, K. M. Metters,, K. R. Lynch,, and J. F. Evans. 2000. Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem. 275: 30531– 30536.
28. Higuchi, K.,, J. Hara,, R. Okamoto,, M. Kawashima,, and G. Imokawa. 2000. The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Biochem. J. 350: 747– 756.
29. Hilkens, C. M.,, A. Snijders,, H. Vermeulen,, P. H. van der Meide,, E. A. Wierenga,, and M. L. Kapsenberg. 1996. Accessory cell-derived IL-12 and prostaglandin E 2 determine the IFN-gamma level of activated human CD4+T cells. J. Immunol. 156: 1722– 1727.
30. Hirai, H.,, K. Tanaka,, O. Yoshie,, K. Ogawa,, K. Kenmotsu,, Y. Takamori,, M. Ichimasa,, K. Sugamura,, M. Nakamura,, S. Takano,, and K. Nagata. 2001. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med. 193: 255– 261.
31. Hui, Y.,, G. Yang,, H. Galczenski,, D. J. Figueroa,, C. P. Austin,, N. G. Copeland,, D. J. Gilbert,, N. A. Jenkins,, and C. D. Funk. 2001. The murine cysteinyl leukotriene 2 (CysLT 2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization. J. Biol. Chem. 276: 47489– 47495.
32. Ishii, I.,, B. Friedman,, X. Ye,, S. Kawamura,, C. McGiffert,, J. J. Contos,, M. A. Kingsbury,, G. Zhang,, J. H. Brown,, and J. Chun. 2001. Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP B3/EDG-3. J. Biol. Chem. 276: 33697– 33704.
33. Ishizaki, J.,, K. Hanasaki,, K. Higashino,, J. Kishino,, N. Kikuchi,, O. Ohara,, and H. Arita. 1994. Molecular cloning of pancreatic group I phospholipase A 2 receptor. J. Biol. Chem. 269: 5897– 5904.
34. Itoh, Y.,, Y. Kawamata,, M. Harada,, M. Kobayashi,, R. Fujii,, S. Fukusumi,, K. Ogi,, M. Hosoya,, Y. Tanaka,, H. Uejima,, H. Tanaka,, M. Maruyama,, R. Satoh,, S. Okubo,, H. Kizawa,, H. Komatsu,, F. Matsumura,, Y. Noguchi,, T. Shinohara,, S. Hinuma,, Y. Fujisawa,, and M. Fujino. 2003. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422: 173– 176.
35. Jakobsson, P. J.,, S. Thoren,, R. Morgenstern,, and B. Samuelsson. 1999. Identification of human prostaglandin E synthase: a microsomal, glutathionedependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl. Acad. Sci. USA 96: 7220– 7225.
36. Jiang, C.,, A. T. Ting,, and B. Seed. 1998. PPARgamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82– 86.
37. Kabarowski, J. H.,, K. Zhu,, L. Q. Le,, O. N. Witte,, and Y. Xu. 2001. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 293: 702– 705.
38. Kanaoka, Y.,, A. Maekawa,, J. F. Penrose,, K. F. Austen,, and B. K. Lam. 2001. Attenuated zymosan-induced peritoneal vascular permeability and IgE-dependent passive cutaneous anaphylaxis in mice lacking leukotriene C4 synthase. J. Biol. Chem. 276: 22608– 22613.
39. Kim, Y. J.,, K. P. Kim,, S. K. Han,, N. M. Munoz,, X. Zhu,, H. Sano,, A. R. Leff,, and W. Cho. 2002. Group V phospholipase A 2 induces leukotriene biosynthesis in human neutrophils through the activation of group IVA phospholipase A2. J. Biol. Chem. 277: 36479– 36488.
40. Koduri, R. S.,, J. O. Gronroos,, V. J. Laine,, C. Le Calvez,, G. Lambeau,, T. J. Nevalainen,, and M. H. Gelb. 2002. Bactericidal properties of human and murine groups I, II,V, X, and XII secreted phospholipases A2. J. Biol. Chem. 277: 5849– 5857.
41. Koh, J. S.,, W. Lieberthal,, S. Heydrick,, and J. S. Levine. 1998. Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway. J. Clin. Invest. 102: 716– 727.
42. Kudo, I.,, and M. Murakami. 2002. Phospholipase A 2 enzymes. Prostag. Other Lipid Mediat. 68- 69: 3– 58.
43. Lam, B. K.,, K. Xu,, M. B. Atkins,, and K. F. Austen. 1992. Leukotriene C4 uses a probenecid-sensitive export carrier that does not recognize leukotriene B 4. Proc. Natl. Acad. Sci. USA 89: 11598– 11602.
44. Lam, B. K.,, J. F. Penrose,, G. J. Freeman,, and K. F. Austen. 1994. Expression cloning of a cDNA for human leukotriene C 4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A 4. Proc. Natl. Acad. Sci. USA 91: 7663– 7667.
45. Lambeau, G.,, and M. Lazdunski. 1999. Receptors for a growing family of secreted phospholipases A 2. Trends Pharmacol. Sci. 20: 162– 170.
46. Langenbach, R.,, S. G. Morham,, H. F. Tiano,, C. D. Loftin,, B. I. Ghanayem,, P. C. Chulada,, J. F. Mahler,, C. A. Lee,, E. H. Goulding,, K. D. Kluckman,, H. S. Kim,, and O. Smithies. 1995. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83: 483– 492.
47. Langenbach, R.,, C. Loftin,, C. Lee,, and H. Tiano. 1999. Cyclooxygenase knockout mice: models for elucidating isoform-specific functions. Biochem. Pharmacol. 58: 1237– 1246.
48. Le, L. Q.,, J. H. Kabarowski,, Z. Weng,, A. B. Satterthwaite,, E. T. Harvill,, E. R. Jensen,, J. F. Miller,, and O. N. Witte. 2001. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 14: 561– 571.
49. Lee, C. W.,, R. A. Lewis,, E. J. Corey,, and K. F. Austen. 1983. Conversion of leukotriene D 4 to leukotriene E4 by a dipeptidase released from the specific granule of human polymorphonuclear leucocytes. Immunology 48: 27– 35.
50. Lee, H.,, J. J. Liao,, M. Graeler,, M. C. Huang,, and E. J. Goetzl. 2002. Lysophospholipid regulation of mononuclear phagocytes. Biochim. Biophys. Acta 1582: 175– 177.
51. Lee, M. J.,, S. Thangada,, K. P. Claffey,, N. Ancellin,, C. H. Liu,, M. Kluk,, M. Volpi,, R. I. Sha'afi,, and T. Hla. 1999. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine- 1-phosphate. Cell 99: 301– 312.
52. Le Stunff, H.,, C. Peterson,, H. Liu,, S. Milstien,, and S. Spiegel. 2002. Sphingosine-1-phosphate and lipid phosphohydrolases. Biochim. Biophys. Acta 1582: 8– 17.
53. Liu, Y.,, R. Wada,, T. Yamashita,, Y. Mi,, C. X. Deng,, J. P. Hobson,, H. M. Rosenfeldt,, V. E. Nava,, S. S. Chae,, M. J. Lee,, C. H. Liu,, T. Hla,, S. Spiegel,, and R. L. Proia. 2000. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106: 951– 961.
54. Lynch, K. R.,, G. P. O'Neill,, Q. Liu,, D. S. Im,, N. Sawyer,, K. M. Metters,, N. Coulombe,, M. Abramovitz,, D. J. Figueroa,, Z. Zeng,, B. M. Connolly,, C. Bai,, C. P. Austin,, A. Chateauneuf,, R. Stocco,, G. M. Greig,, S. Kargman,, S. B. Hooks,, E. Hosfield,, D. L. Williams, Jr.,, A. W. Ford-Hutchinson,, C. T. Caskey,, and J. F. Evans. 1999. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399: 789– 793.
55. MacLennan, A. J.,, P. R. Carney,, W. J. Zhu,, A. H. Chaves,, J. Garcia,, J. R. Grimes,, K. J. Anderson,, S. N. Roper,, and N. Lee. 2001. An essential role for the H218/AGR16/Edg-5/LP B2 sphingosine 1-phosphate receptor in neuronal excitability. Eur. J. Neurosci. 14: 203– 209.
56. Maekawa, A.,, Y. Kanaoka,, B. K. Lam,, and K. F. Austen. 2001. Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing. Proc. Natl.Acad. Sci.USA 98: 2256– 2261.
57. Maekawa, A.,, K. F. Austen,, and Y. Kanaoka. 2002. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses. J. Biol. Chem. 277: 20820– 20824.
58. Mancini, J. A.,, K. Blood,, J. Guay,, R. Gordon,, D. Claveau,, C. C. Chan,, and D. Riendeau. 2001. Cloning, expression, and up-regulation of inducible rat prostaglandin E synthase during lipopolysaccharide- induced pyresis and adjuvant-induced arthritis. J. Biol. Chem. 276: 4469– 4475.
59. Matsumoto, T.,, C. D. Funk,, O. Radmark,, J. O. Hoog,, H. Jornvall,, and B. Samuelsson. 1988. Molecular cloning and amino acid sequence of human 5-lipoxygenase. Proc. Natl. Acad. Sci. USA 85: 26– 30.
60. Matsuoka, T.,, M. Hirata,, H. Tanaka,, Y. Takahashi,, T. Murata,, K. Kabashima,, Y. Sugimoto,, T. Kobayashi,, F. Ushikubi,, Y. Aze,, N. Eguchi,, Y. Urade,, N. Yoshida,, K. Kimura,, A. Mizoguchi,, Y. Honda,, H. Nagai,, and S. Narumiya. 2000. Prostaglandin D 2 as a mediator of allergic asthma. Science 287: 2013– 2017.
61. Mellor, E. A.,, K. F. Austen,, and J. A. Boyce. 2002. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J. Exp. Med. 195: 583– 592.
62. Miller, D. K.,, J. W. Gillard,, P. J. Vickers,, S. Sadowski,, C. Leveille,, J. A. Mancini,, P. Charleson,, R. A. Dixon,, A.W. Ford-Hutchinson,, R. Fortin,, J.Y. Gauthier,, J. Rodkey,, R. Rosen,, C. Rouzer,, I. S. Sigal,, C. D. Strader,, and J. F. Evans. 1990. Identification and isolation of a membrane protein necessary for leukotriene production. Nature 343: 278– 281.
63. Minami, M.,, S. Ohno,, H. Kawasaki,, O. Radmark,, B. Samuelsson,, H. Jornvall,, T. Shimizu,, Y. Seyama,, and K. Suzuki. 1987. Molecular cloning of a cDNA coding for human leukotriene A 4 hydrolase. Complete primary structure of an enzyme involved in eicosanoid synthesis. J. Biol. Chem. 262: 13873– 13876.
64. Morham, S. G.,, R. Langenbach,, C. D. Loftin,, H. F. Tiano,, N. Vouloumanos,, J. C. Jennette,, J. F. Mahler,, K. D. Kluckman,, A. Ledford,, C. A. Lee,, and O. Smithies. 1995. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83: 473– 482.
65. Murata, T.,, F. Ushikubi,, T. Matsuoka,, M. Hirata,, A. Yamasaki,, Y. Sugimoto,, A. Ichikawa,, Y. Aze,, T. Tanaka,, N. Yoshida,, A. Ueno,, S. Oh-ishi,, and S. Narumiya. 1997. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388: 678– 682.
66. Narumiya, S.,, and G.A. FitzGerald. 2001. Genetic and pharmacological analysis of prostanoid receptor function. J. Clin. Invest. 108: 25– 30.
67. Nataraj, C.,, D. W. Thomas,, S. L. Tilley,, M. T. Nguyen,, R. Mannon,, B. H. Koller,, and T. M. Coffman. 2001. Receptors for prostaglandin E 2 that regulate cellular immune responses in the mouse. J. Clin. Invest. 108: 1229– 1235.
68. Ogasawara, H.,, S. Ishii,, T. Yokomizo,, T. Kakinuma,, M. Komine,, K. Tamaki,, T. Shimizu,, and T. Izumi. 2002. Characterization of mouse cysteinyl leukotriene receptors mCysLT 1 and mCysLT 2: differential pharmacological properties and tissue distribution. J. Biol. Chem. 277: 18763– 18768.
69. Oka, S.,, and H. Arita. 1991. Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J. Biol. Chem. 266: 9956– 9960.
70. Rao, T. S.,, J. L. Currie,, A. F. Shaffer,, and P. C. Isakson. 1994. In vivo characterization of zymosan-induced mouse peritoneal inflammation. J. Pharmacol. Exp.Ther. 269: 917– 925.
71. Ricote, M.,, A. C. Li,, T. M. Willson,, C. J. Kelly,, and C. K. Glass. 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79– 82.
72. Rossi, A.,, P. Kapahi,, G. Natoli,, T. Takahashi,, Y. Chen,, M. Karin,, and M. G. Santoro. 2000. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403: 103– 108.
73. Rouzer, C. A.,, W. A. Scott,, Z. A. Cohn,, P. Blackburn,, and J. M. Manning. 1980. Mouse peritoneal macrophages release leukotriene C in response to a phagocytic stimulus. Proc. Natl. Acad. Sci. USA 77: 4928– 4932.
74. Sawada, H.,, M. Murakami,, A. Enomoto,, S. Shimbara,, and I. Kudo. 1999. Regulation of type V phospholipase A 2 expression and function by proinflammatory stimuli. Eur. J. Biochem. 263: 826– 835.
75. Sharp, J. D.,, D. L. White,, X. G. Chiou,, T. Goodson,, G. C. Gamboa,, D. McClure,, S. Burgett,, J. Hoskins,, P. L. Skatrud,, J. R. Sportsman,, G. W. Becker,, L. H. Kang,, E. F. Roberts,, and R. M. Kramer. 1991. Molecular cloning and expression of human Ca 2+-sensitive cytosolic phospholipase A2. J. Biol. Chem. 266: 14850– 14853.
76. Shi, Z. Z.,, B. Han,, G. M. Habib,, M. M. Matzuk,, and M.W. Lieberman. 2001. Disruption of gammaglutamyl leukotrienase results in disruption of leukotriene D 4 synthesis in vivo and attenuation of the acute inflammatory response. Mol. Cell. Biol. 21: 5389– 5395.
77. Shinomiya, S.,, H. Naraba,, A. Ueno,, I. Utsunomiya,, T. Maruyama,, S. Ohuchida,, F. Ushikubi,, K. Yuki,, S. Narumiya,, Y. Sugimoto,, A. Ichikawa,, and S. Oh-ishi. 2001. Regulation of TNFalpha and interleukin-10 production by prostaglandins I 2 and E 2: studies with prostaglandin receptor- deficient mice and prostaglandin E-receptor subtype- selective synthetic agonists. Biochem. Pharmacol. 61: 1153– 1160.
78. Singer, A. G.,, F. Ghomashchi,, C. Le Calvez,, J. Bollinger,, S. Bezzine,, M. Rouault,, M. Sadilek,, E. Nguyen,, M. Lazdunski,, G. Lambeau,, and M. H. Gelb. 2002. Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A 2. J. Biol. Chem. 277: 48535– 48549.
79. Straus, D. S.,, G. Pascual,, M. Li,, J. S. Welch,, M. Ricote,, C. H. Hsiang,, L. L. Sengchanthalangsy,, G. Ghosh,, and C. K. Glass. 2000. 15-deoxydelta 12, 14- prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc. Natl. Acad. Sci. USA 97: 4844– 4849.
80. Sugimoto, Y.,, A. Yamasaki,, E. Segi,, K. Tsuboi,, Y. Aze,, T. Nishimura,, H. Oida,, N. Yoshida,, T. Tanaka,, M. Katsuyama,, K. Hasumoto,, T. Murata,, M. Hirata,, F. Ushikubi,, M. Negishi,, A. Ichikawa,, and S. Narumiya. 1997. Failure of parturition in mice lacking the prostaglandin F receptor. Science 277: 681– 683.
81. Tager, A. M.,, J. H. Dufour,, K. Goodarzi,, S. D. Bercury,, U. H. von Andrian,, and A. D. Luster. 2000. BLTR mediates leukotriene B4-induced chemotaxis and adhesion and plays a dominant role in eosinophil accumulation in a murine model of peritonitis. J. Exp. Med. 192: 439– 446.
82. Tanikawa, N.,, Y. Ohmiya,, H. Ohkubo,, K. Hashimoto,, K. Kangawa,, M. Kojima,, S. Ito,, and K. Watanabe. 2002. Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem. Biophys. Res. Commun. 291: 884– 889.
83. Tanioka, T.,, Y. Nakatani,, N. Semmyo,, M. Murakami,, and I. Kudo. 2000. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E 2 biosynthesis. J. Biol. Chem. 275: 32775– 32782.
84. Tilley, S. L.,, T. M. Coffman,, and B. H. Koller. 2001. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108: 15– 23.
85. Tokumura, A.,, E. Majima,, Y. Kariya,, K. Tominaga,, K. Kogure,, K. Yasuda,, and K. Fukuzawa. 2002. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 277: 39436– 39442.
86. Uematsu, S.,, M. Matsumoto,, K. Takeda,, and S. Akira. 2002. Lipopolysaccharide-dependent prostaglandin E 2 production is regulated by the glutathionedependent prostaglandin E 2 synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J. Immunol. 168: 5811– 5816.
87. Uozumi, N.,, K. Kume,, T. Nagase,, N. Nakatani,, S. Ishii,, F. Tashiro,, Y. Komagata,, K. Maki,, K. Ikuta,, Y. Ouchi,, J. Miyazaki,, and T. Shimizu. 1997. Role of cytosolic phospholipase A 2 in allergic response and parturition. Nature 390: 618– 622.
88. Ushikubi, F.,, Y. Aiba,, K. Nakamura,, T. Namba,, M. Hirata,, O. Mazda,, Y. Katsura,, and S. Narumiya. 1993. Thromboxane A 2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. J. Exp. Med. 178: 1825– 1830.
89. van der Pouw Kraan, T. C.,, L. C. Boeije,, R. J. Smeenk,, J. Wijdenes,, and L. A. Aarden. 1995. Prostaglandin-E 2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181: 775– 779.
90. Watanabe, K.,, K. Kurihara,, and T. Suzuki. 1999. Purification and characterization of membrane-bound prostaglandin E synthase from bovine heart. Biochim. Biophys. Acta 1439: 406– 414.
91. Weinrauch, Y.,, P. Elsbach,, L. M. Madsen,, A. Foreman,, and J. Weiss. 1996. The potent anti- Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A 2. J. Clin. Invest. 97: 250– 257.
92. Welsch, D. J.,, D. P. Creely,, S. D. Hauser,, K. J. Mathis,, G. G. Krivi,, and P. C. Isakson. 1994. Molecular cloning and expression of human leukotriene-C 4 synthase. Proc. Natl. Acad. Sci. USA 91: 9745– 9749.
93. Xia, P.,, J. R. Gamble,, K. A. Rye,, L. Wang,, C. S. Hii,, P. Cockerill,, Y. Khew-Goodall,, A. G. Bert,, P. J. Barter,, and M. A. Vadas. 1998. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc. Natl. Acad. Sci. USA 95: 14196– 14201.
94. Xu, Y. 2002. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim. Biophys. Acta 1582: 81– 88.
95. Yokomizo, T.,, T. Izumi,, K. Chang,, Y. Takuwa,, and T. Shimizu. 1997. A G-protein-coupled receptor for leukotriene B 4 that mediates chemotaxis. Nature 387: 620– 624.
96. Yokomizo, T.,, K. Kato,, K. Terawaki,, T. Izumi,, and T. Shimizu. 2000. A second leukotriene B 4 receptor,BLT2.A new therapeutic target in inflammation and immunological disorders. J. Exp. Med. 192: 421– 432.
97. Yokota, Y.,, K. Higashino,, K. Nakano,, H. Arita,, and K. Hanasaki. 2000. Identification of group X secretory phospholipase A 2 as a natural ligand for mouse phospholipase A 2 receptor. FEBS Lett. 478: 187– 191.
98. Zhou, D.,, W. Luini,, S. Bernasconi,, L. Diomede,, M. Salmona,, A. Mantovani,, and S. Sozzani. 1995. Phosphatidic acid and lysophosphatidic acid induce haptotactic migration of human monocytes. J. Biol. Chem. 270: 25549– 25556.

Tables

Lipids
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817671.chap21-1,webId=/content/author/10.1128/9781555817671.chap21-1,properties={foaf_givenname=K. Frank, foaf_name=K. Frank Austen, foaf_surname=Austen, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555817671.chap21-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817671.chap21-2,webId=/content/author/10.1128/9781555817671.chap21-2,properties={foaf_givenname=Yoshihide, foaf_name=Yoshihide Kanaoka, foaf_surname=Kanaoka, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555817671.chap21-aff1]]}]]
Citation: Austen K, Kanaoka Y. 2004. Lipids, p 417-432. In Kaufmann S, Medzhitov R, Gordon S (ed), The Innate Immune Response to Infection. ASM Press, Washington, DC. doi: 10.1128/9781555817671.ch21
/content/10.1128/9781555817671.chap21.tab21-1
TABLE 1

Innate immune responses in mice lacking eicosanoid synthetic enzymes and receptors

10.1128/9781555817671/tab21-1_thmb.gif
10.1128/9781555817671/tab21-1.gif
Generic image for table
TABLE 1

Innate immune responses in mice lacking eicosanoid synthetic enzymes and receptors

Citation: Austen K, Kanaoka Y. 2004. Lipids, p 417-432. In Kaufmann S, Medzhitov R, Gordon S (ed), The Innate Immune Response to Infection. ASM Press, Washington, DC. doi: 10.1128/9781555817671.ch21

Back to top
This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error